The global urinary incontinence devices market was valued at $1,611 million in 2016, and is expected to reach $3,411 million by 2023, registering a CAGR of 11.3% during the forecast period. Urinary incontinence devices aid in collecting and holding urine; such devices help manage urinary incontinence effectively. Patients suffer from urine leakage that cannot be controlled. If the condition is severe, the patient is recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).
Development of innovative urinary incontinence devices along with increase in aging population that is highly susceptible to urological conditions drive the market. In addition, the increase in the urinary incontinent patients transitioning from conventional solutions is set to increase in near future. Further high risk of associative urological conditions among people supplement the growth of the market. However, lack of awareness regarding novel developments in the urinary incontinence devices, and post-operative complications associated with the devices hamper the market growth. Moreover, the growth in healthcare expenditures in the developing economies is anticipated to create numerous opportunities for key vendors in this market.
The global urinary incontinence devices market is segmented based on product, category, incontinence type, end user, and region. Based on product, the market is divided into urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and other devices. The urinary catheters are further categorized into Foley catheters and other urinary catheters. Whereas, vaginal slings is sub-segmented into conventional vaginal slings and advanced vaginal slings. Based on category, the market is bifurcated into external urinary incontinence devices and internal urinary incontinence devices. Based on incontinence type, the market is segmented into stress incontinence, urge incontinence, overflow incontinence, and functional incontinence. Further, based on end user, the market is classified into hospitals, clinics, and other.
Based on region, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major companies profiled in the report include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global urinary incontinence devices market with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry is provided from 2016 to 2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the trends in urinary incontinence devices globally.
Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product
Urinary Catheters
Foley Catheters
Other Urinary Catheters
Vaginal Slings
Conventional Vaginal slings
Advanced Vaginal Slings
Electrical Stimulation Devices
Artificial Urinary Sphincters
Other Devices
By Category
External Urinary Incontinence Devices
Internal Urinary Incontinence Devices
By Incontinence Type
Stress Incontinence
Urge Incontinence
Overflow Incontinence
Functional Incontinence
By End User
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Turkey
Saudi Arabia
Rest of LAMEA
KEY MARKET PLAYERS
Coloplast
Boston Scientific Corporation
C. R. Bard, Inc.
ConvaTec Group Plc
Ethicon Inc
Caldera Medical Inc
Cook Medical
Covidien (Medtronic)
Prosurg, Inc.
Cogentix Medical Inc
Development of innovative urinary incontinence devices along with increase in aging population that is highly susceptible to urological conditions drive the market. In addition, the increase in the urinary incontinent patients transitioning from conventional solutions is set to increase in near future. Further high risk of associative urological conditions among people supplement the growth of the market. However, lack of awareness regarding novel developments in the urinary incontinence devices, and post-operative complications associated with the devices hamper the market growth. Moreover, the growth in healthcare expenditures in the developing economies is anticipated to create numerous opportunities for key vendors in this market.
The global urinary incontinence devices market is segmented based on product, category, incontinence type, end user, and region. Based on product, the market is divided into urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and other devices. The urinary catheters are further categorized into Foley catheters and other urinary catheters. Whereas, vaginal slings is sub-segmented into conventional vaginal slings and advanced vaginal slings. Based on category, the market is bifurcated into external urinary incontinence devices and internal urinary incontinence devices. Based on incontinence type, the market is segmented into stress incontinence, urge incontinence, overflow incontinence, and functional incontinence. Further, based on end user, the market is classified into hospitals, clinics, and other.
Based on region, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major companies profiled in the report include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global urinary incontinence devices market with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry is provided from 2016 to 2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the trends in urinary incontinence devices globally.
Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product
Urinary Catheters
Foley Catheters
Other Urinary Catheters
Vaginal Slings
Conventional Vaginal slings
Advanced Vaginal Slings
Electrical Stimulation Devices
Artificial Urinary Sphincters
Other Devices
By Category
External Urinary Incontinence Devices
Internal Urinary Incontinence Devices
By Incontinence Type
Stress Incontinence
Urge Incontinence
Overflow Incontinence
Functional Incontinence
By End User
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Turkey
Saudi Arabia
Rest of LAMEA
KEY MARKET PLAYERS
Coloplast
Boston Scientific Corporation
C. R. Bard, Inc.
ConvaTec Group Plc
Ethicon Inc
Caldera Medical Inc
Cook Medical
Covidien (Medtronic)
Prosurg, Inc.
Cogentix Medical Inc
Frequently Asked Questions about the Global Urinary Incontinence Devices Market
What is the estimated value of the Global Urinary Incontinence Devices Market?
What is the growth rate of the Global Urinary Incontinence Devices Market?
What is the forecasted size of the Global Urinary Incontinence Devices Market?
Note: Product cover images may vary from those shown
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: URINARY INCONTINENCE DEVICES MARKET BY PRODUCT
CHAPTER 5: URINARY INCONTINENCE DEVICES MARKET BY INCONTINENCE TYPE
CHAPTER 6: URINARY INCONTINENCE DEVICES MARKET BY CATEGORY
CHAPTER 7: URINARY INCONTINENCE DEVICES MARKET BY END USER
CHAPTER 8: URINARY INCONTINENCE DEVICES MARKET BY REGION
CHAPTER 9: COMPANY PROFILES
Note: Product cover images may vary from those shown
According to a new report titled, Urinary Incontinence Devices Market by Product, Category, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the urinary incontinence devices market was valued at $1,611 million in 2016, and is projected to reach $3,411 million by 2023, growing at a CAGR of 11.3% from 2017 to 2023. The internal urinary incontinence devices segment accounted for three-fifths share of the market in 2016.
Urinary incontinence is a highly prevalent condition and is considered to be an underreported problem that increases with age that affects nearly 50% of the geriatric population. Urinary incontinence is categorized into four major types namely stress urinary incontinence, urge urinary incontinence, mixed urinary incontinence, and functional urinary incontinence. Stress urine leakage is associated with increased abdominal pressure from laughing, sneezing, coughing, climbing stairs, or other physical factors that assert stress on the abdominal cavity. Whereas, urge incontinence is the involuntary leakage accompanied by urgency. Among the four above mentioned types of urinary incontinence, stress and urge are most commonly prevalent among men and women.
Urinary incontinence has a major impact on the emotional, psychological, and social life; maximum number of patients suffering from urinary incontinence cannot perform regular activities confidently. This propels the development of effective solutions for the treatment of the same. According to the Urology Care Foundation, a quarter to a third of men and women in the U.S. suffer from urinary incontinence per year. This also indicates that approximately 33 million of the U.S. residents have overactive bladder that represent symptoms of urgency and frequency leading to the urge in the usage of urinary incontinence devices.
Some of the other factors responsible for substantial market growth include development of innovative urinary incontinence devices, increase in aging population coupled with high risk of urological conditions, and increase in the urinary incontinent patients transitioning from conventional solutions to advanced surgical treatments. Factors such as lack of awareness regarding novel developments in the urinary incontinence devices and post-operative complications associated with the devices restrict the market growth to a certain extent. Moreover, growth in healthcare expenditures in the developing economies offers lucrative opportunities for the market players to invest in these economies.
Vaginal slings generated the highest revenue in 2016, accounting for about two-fifths of the total market. This is attributed to the high contribution of the conventional vaginal slings in the vaginal slings market owing to the high preference for the use of biomaterials in surgical treatment of incontinence. Advancements in the conventional vaginal slings assist in eliminating the post-operative complications associated with the vaginal sling surgeries and several key players are developing conventional slings using advanced synthetic materials to meet the patients requirement. In addition, the advanced vaginal slings have witnessed increased adoption in the surgical treatment of urinary incontinence among women owing to their minimal invasive nature.
Based on incontinence type, stress incontinence generated the highest revenue in 2016 accounting for about half of the total share of the market and is anticipated to continue this trend throughout the forecast period. Pregnancy as well as childbirth result in the stretching and weakening of a womans pelvic floor muscles which causes stress urinary incontinence. In addition, prostate surgeries in men can also result in stress urinary incontinence. This has made stress urinary incontinence the most prevalent conditions among men and women.
Key findings of the Urinary Incontinence Devices Market:
The Internal urinary incontinence devices segment generated the highest revenue in 2016 and is anticipated to do so throughout the forecast period, registering a CAGR of 12.3% from 2017 to 2023.
Hospitals dominated the end user market, accounting for maximum share in global market in 2016 and is expected to witness a CAGR of 10.1% from 2017 to 2023.
North America dominated the market, accounting for maximum share in 2016 and is expected to retain the same trend during 2017 to 2023.
Japan accounted for two-sevenths share of the Asia-Pacific urinary incontinence devices market in 2016.
Asia-Pacific is expected to witness the highest growth rate for urinary incontinence devices market throughout the forecast period. Asia-Pacific offers lucrative opportunities for players that operate in the urinary incontinence devices market due to its high population base, growth in disposable incomes, and improvement in patient awareness about advanced urinary incontinence management. Japan, India, and China are among the leading countries for prevalence of urinary incontinence in Asia-Pacific, which further contributes to the robust growth displayed by this region in the global market
The key players in this market have adopted product launch as one of their key developmental strategies such as acquisitions and product launches. The major companies profiled in this report include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc. Other players (profiles not included in the report) in the value chain analysis include, Sofradim, B Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Karl Storz GmbH & Co. KG, Nipro Corporation, Olympus Corporation, ABISS, and Betatech Medical.
Urinary incontinence is a highly prevalent condition and is considered to be an underreported problem that increases with age that affects nearly 50% of the geriatric population. Urinary incontinence is categorized into four major types namely stress urinary incontinence, urge urinary incontinence, mixed urinary incontinence, and functional urinary incontinence. Stress urine leakage is associated with increased abdominal pressure from laughing, sneezing, coughing, climbing stairs, or other physical factors that assert stress on the abdominal cavity. Whereas, urge incontinence is the involuntary leakage accompanied by urgency. Among the four above mentioned types of urinary incontinence, stress and urge are most commonly prevalent among men and women.
Urinary incontinence has a major impact on the emotional, psychological, and social life; maximum number of patients suffering from urinary incontinence cannot perform regular activities confidently. This propels the development of effective solutions for the treatment of the same. According to the Urology Care Foundation, a quarter to a third of men and women in the U.S. suffer from urinary incontinence per year. This also indicates that approximately 33 million of the U.S. residents have overactive bladder that represent symptoms of urgency and frequency leading to the urge in the usage of urinary incontinence devices.
Some of the other factors responsible for substantial market growth include development of innovative urinary incontinence devices, increase in aging population coupled with high risk of urological conditions, and increase in the urinary incontinent patients transitioning from conventional solutions to advanced surgical treatments. Factors such as lack of awareness regarding novel developments in the urinary incontinence devices and post-operative complications associated with the devices restrict the market growth to a certain extent. Moreover, growth in healthcare expenditures in the developing economies offers lucrative opportunities for the market players to invest in these economies.
Vaginal slings generated the highest revenue in 2016, accounting for about two-fifths of the total market. This is attributed to the high contribution of the conventional vaginal slings in the vaginal slings market owing to the high preference for the use of biomaterials in surgical treatment of incontinence. Advancements in the conventional vaginal slings assist in eliminating the post-operative complications associated with the vaginal sling surgeries and several key players are developing conventional slings using advanced synthetic materials to meet the patients requirement. In addition, the advanced vaginal slings have witnessed increased adoption in the surgical treatment of urinary incontinence among women owing to their minimal invasive nature.
Based on incontinence type, stress incontinence generated the highest revenue in 2016 accounting for about half of the total share of the market and is anticipated to continue this trend throughout the forecast period. Pregnancy as well as childbirth result in the stretching and weakening of a womans pelvic floor muscles which causes stress urinary incontinence. In addition, prostate surgeries in men can also result in stress urinary incontinence. This has made stress urinary incontinence the most prevalent conditions among men and women.
Key findings of the Urinary Incontinence Devices Market:
The Internal urinary incontinence devices segment generated the highest revenue in 2016 and is anticipated to do so throughout the forecast period, registering a CAGR of 12.3% from 2017 to 2023.
Hospitals dominated the end user market, accounting for maximum share in global market in 2016 and is expected to witness a CAGR of 10.1% from 2017 to 2023.
North America dominated the market, accounting for maximum share in 2016 and is expected to retain the same trend during 2017 to 2023.
Japan accounted for two-sevenths share of the Asia-Pacific urinary incontinence devices market in 2016.
Asia-Pacific is expected to witness the highest growth rate for urinary incontinence devices market throughout the forecast period. Asia-Pacific offers lucrative opportunities for players that operate in the urinary incontinence devices market due to its high population base, growth in disposable incomes, and improvement in patient awareness about advanced urinary incontinence management. Japan, India, and China are among the leading countries for prevalence of urinary incontinence in Asia-Pacific, which further contributes to the robust growth displayed by this region in the global market
The key players in this market have adopted product launch as one of their key developmental strategies such as acquisitions and product launches. The major companies profiled in this report include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc. Other players (profiles not included in the report) in the value chain analysis include, Sofradim, B Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Karl Storz GmbH & Co. KG, Nipro Corporation, Olympus Corporation, ABISS, and Betatech Medical.
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
